Reducing the use of OCS in the management of asthma

In this latest ERS Vision film, Prof. Christopher Brightling, Prof. Arnaud Bourdin, Prof. David Price and a Patient, look at the benefits and risks of using OCS in the management of Asthma.



The ERS Vision film series is made possible through a foundation sponsorship by astrazeneca